ArticleFrontiers in pharmacology2022

Umbelliferone and scopoletin target tyrosine kinases on fibroblast-like synoviocytes to block NF-κB signaling to combat rheumatoid arthritis.

Qilei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.